Nurix Therapeutics, Inc. NRIX Preferred Stock, Par or Stated Value Per Share
Preferred Stock, Par or Stated Value Per Share at other companies
Other financials
Where this comes from
Reported directly by Nurix Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockParOrStatedValuePerShare.
The official record: Nurix Therapeutics, Inc.’s 10-Q, filed April 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share?
- Nurix Therapeutics, Inc. (NRIX) reported preferred stock, par or stated value per share of $0 in Q4 2025.
- How has Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share changed year-over-year?
- Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share decreased by 0.0% year-over-year, from $0 to $0.
- What is the long-term trend for Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share?
- Over 3 years (2022 to 2025), Nurix Therapeutics, Inc.'s preferred stock, par or stated value per share has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.